9/30/2021CBMG Holdings Completes $120 Million in Series A Funding

9/30/2021Biden Admin Urged by Congressional Members to Blacklist BGI and Select...

9/30/2021China Upholds Healthcare Cost Containment as It Seeks to Enhance Acces...

9/29/2021IQVIA: Chinese Retail Pharmacy Sales Up 0.9% in Q2/2021

9/29/2021PhIIC: Chinese Hospital Drugs Sales Jumps 17.9% in H1 after Decline La...

9/29/2021SMEI: Chinese Hospital Chemical Drug Sales Rebounded 17.83% in H1 Led ...

9/29/2021State Council Issues the 14th Five Year Plan for Universal Healthcare ...

9/29/2021Bloomberg: I-Mab Eyes Biopharma Partnerships, Possible Equity Sale

9/29/2021HUTCHMED Closes Divestment of Non-Core Chinese OTC Joint Venture

9/29/2021Zhaoke Ophthalmology's Chinese IND for Potential First Myopia Drug NVK...

9/29/2021iX Biopharma Enters Deal with China Resources Pharma for ED Drug Wafe...

9/28/2021JW Therapeutics Granted Chinese Approval of T-Cell Therapy for Large B...

9/28/2021NHSA Completes Expert Review of Product Applications for 2021 NRDL

9/28/2021Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti...

9/28/2021I-Mab's Chinese IND Accepted for P2 Trial of Enoblituzumab in Combo wi...

9/28/2021Genelux and Newsoara Announce License Deal for Oncolytic Immunotherapi...

9/28/2021China's "Hatch-Waxman" System: A Comparative Overview

9/27/2021CDE Solicits Public Comments on Draft of the Technical Guidelines for ...

9/27/2021CDE Solicits Public Comments on Draft of the Technical Guidelines for ...

9/27/2021JW Therapeutics Granted Chinese IND Approval for Multiple Myeloma CAR ...

9/27/2021Bio-Thera and Intract Pharma Enter License Pact for Soteria and Phlora...

9/27/2021Innovent and UNION Therapeutics Enter License Deal for Next-generation...

9/27/2021Beijing Wantai to Initiate Trial for Nasal Spray COVID-19 Vaccine Cand...

9/27/2021Neurophth Completes GMP Manufacturing Facility for Gene Therapy Produ...

9/27/2021Transcenta Cleared for Chinese IND of Anti-sclerostin mAb TST002

9/24/2021Everest Medicines Announces IND Approval of Class 1 Anti-infective SPR...

9/24/2021Akeso's Chinese NDA for Cadonilimab Accepted by NMPA

9/24/2021Healthcare Units of Chinese IT Giants Under Pressure As State Media C...

9/24/2021Review of Performance Results of Listed Chinese Pharma Companies H1/20...

9/24/2021Review of R&D Investments of Selected Listed Chinese Pharma Companies ...

Page:112/719 Total number of articles:21546: [First][<<] [110] [111] [112] [113] [114] [>>] [End]